ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

EPIX ESSA Pharma Inc

1.61
-0.02 (-1.23%)
24 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
ESSA Pharma Inc NASDAQ:EPIX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.02 -1.23% 1.61 1.58 1.63 1.63 1.59 1.61 40,449 22:00:00

ESSA Pharma to Present at the 2024 Cantor Global Healthcare Conference

11/09/2024 9:05pm

PR Newswire (US)


ESSA Pharma (NASDAQ:EPIX)
Historical Stock Chart


From Jun 2024 to Dec 2024

Click Here for more ESSA Pharma Charts.

SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, Sept. 11, 2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for treatment of prostate cancer, today announced that the Company will be presenting at the 2024 Cantor Global Healthcare Conference on Wednesday, September 18, 2024, at 9:10 a.m. ET in New York, NY.

David R. Parkinson, President and Chief Executive Officer, Peter Virsik, Chief Operating Officer and Executive Vice President, and David S. Wood, Chief Financial Officer, will participate in a fireside chat.

A live webcast of the fireside chat can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the event, the webcast will be archived on the ESSA website for 90 days.

About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essaphrma.com, and follow us on X and LinkedIn.

Contacts  
ESSA Pharma Inc.
Peter Virsik, Chief Operating Officer
778.331.0962
pvirsik@essapharma.com

Investors and Media:
Argot Partners
212.600.1902
essa@argotpartners.com 

Cision View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-the-2024-cantor-global-healthcare-conference-302244410.html

SOURCE ESSA Pharma Inc

Copyright 2024 PR Newswire

1 Year ESSA Pharma Chart

1 Year ESSA Pharma Chart

1 Month ESSA Pharma Chart

1 Month ESSA Pharma Chart

Your Recent History

Delayed Upgrade Clock